Daniel DiStefano
10Patents
3h-index
13Co-inventors
57Inventor score
Filing activity: Oct 21, 1998 → Apr 9, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9011876B2 | Live, attenuated respiratory syncytial virus | Chemistry; Metallurgy | 6 | Active |
| US6656719B1 | Serum-free, low-protein media for rotavirus vaccine production | Chemistry; Metallurgy | 5 | Expired |
| US10072072B2 | Antibody neutralizing human respiratory syncytial virus | Emerging Cross-Sectional Technologies | 3 | Active |
| US9963500B2 | Antibody neutralizing human respiratory syncytial virus | Emerging Cross-Sectional Technologies | 2 | Active |
| US11981726B2 | Antibody neutralizing human respiratory syncytial virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US11008380B2 | Antibody neutralizing human respiratory syncytial virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US10323079B2 | Antibody neutralizing human respiratory syncytial virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US12371478B2 | Antibody neutralizing human respiratory syncytial virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US10358480B2 | Antibody neutralizing human respiratory syncytial virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US11566065B2 | Antibody neutralizing human respiratory syncytial virus | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.